View in EDS

Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation.

Saved in:
Bibliographic Details
Title: Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation.
Authors: Dimou, Anastasios1, Ou, Sai-Hong I.2, Doebele, Robert C.1 robert.doebele@ucdenver.edu
Source: JCO Precision Oncology. 6/3/2019, Vol. 3, p1-6. 6p.
Database: Academic Search Ultimate
Description
ISSN:24734284
DOI:10.1200/PO.19.00013